Skip to main content

Table 4 Multivariate analysis of risk factor s for developing SSI

From: Clinical study of a new skin antiseptic olanexidine gluconate in gastrointestinal cancer surgery

Factor Effect size (95% CI) P value
Age 1.09 (0.982–1.200) 0.107
Male gender 2.04 (0.418–9.990) 0.378
Diabetes mellitus 3.67 (0.908–14.900) 0.068
Anticoagulant 1.44 (0.310–6.690) 0.642
ASA (1.2 or 3) 1.87 (0.413–8.440) 0.417
Site (stomach or colon) 0.217 (0.0200–2.360) 0.209
Approach (open or laparoscopy) 0.636 (0.138–2.930) 0.562
Use of olanexidine 0.160 (0.0365–0.700) 0.0150
Complication except SSI 2.60 (0.657–10.300) 0.173